Heisenberg-Professur für Molekulare Mechanismen der Organfibrose

Adresse:
Krankenhausstraße 12
91054 Erlangen


Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 9 Go to next page Go to last page

Henderson, J., Distler, J., & O'Reilly, S. (2019). The Role of Epigenetic Modifications in Systemic Sclerosis: A Druggable Target. Trends in Molecular Medicine, 25(5), 395-411. https://dx.doi.org/10.1016/j.molmed.2019.02.001
Heim, C., Mauer, J., Kuckhahn, A., Distler, J., Spriewald, B., Ramsperger-Gleixner, M.,... Ensminger, S.M. (2019). Receptor Tyrosine Kinase Inhibitor Nintedanib as Treatment Option in Bronchiolitis Obliterans after Airway Transplantation. In JOURNAL OF HEART AND LUNG TRANSPLANTATION (pp. S139-S139). Orlando, FL, US: NEW YORK: ELSEVIER SCIENCE INC.
Wollin, L., Distler, J., Redente, E., Riches, D., Stowasser, S., & Schlenker-Herceg, R. (2019). FROM BENCH TO BEDSIDE: NINTEDANIB FOR PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES. In RESPIROLOGY (pp. 171-171). HOBOKEN: WILEY.
Harrach, S., Barz, V., Pap, T., Pavenstaedt, H., Schlatter, E., Edemir, B.,... Bertrand, J. (2019). Notch Signaling Activity Determines Uptake and Biological Effect of Imatinib in Systemic Sclerosis Dermal Fibroblasts. Journal of Investigative Dermatology, 139(2), 439-447. https://dx.doi.org/10.1016/j.jid.2018.08.021
Wollin, L., Distler, J., Denton, C.P., & Gahlemann, M. (2019). Rationale for the evaluation of nintedanib as a treatment for systemic sclerosis–associated interstitial lung disease. Journal of Scleroderma and Related Disorders. https://dx.doi.org/10.1177/2397198319841842
Kreuter, M., Bonella, F., Blank, N., Siegert, E., Henes, J., Worm, M.,... Hunzelmann, N. (2019). Predictors for the Development of Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) - Data from the German SSc-Network. In AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. Dallas, TX, US: NEW YORK: AMER THORACIC SOC.
Elhai, M., Boubaya, M., Distler, O., Smith, V., Matucci-Cerinic, M., Alegre Sancho, J.J.,... Allanore, Y. (2019). Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: A prospective cohort study. Annals of the Rheumatic Diseases. https://dx.doi.org/10.1136/annrheumdis-2018-214816
Wohlfahrt, T., Rauber, S., Uebe, S., Luber, M., Soare, A., Ekici, A.B.,... Ramming, A. (2019). PU.1 controls fibroblast polarization and tissue fibrosis. Nature. https://dx.doi.org/10.1038/s41586-019-0896-x
Knitza, J., Cavagna, L., Schett, G., & Distler, J. (2019). Response to: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: Contribution of antisynthetase antibodies to improve current classification criteria' by Greco et al. Annals of the Rheumatic Diseases. https://dx.doi.org/10.1136/annrheumdis-2019-215484
Distler, J. (2018). New molecular mechanisms in the pathophysiology of rheumatic diseases. Zeitschrift für Rheumatologie, 77(9), 766-768. https://dx.doi.org/10.1007/s00393-018-0543-1
Gocht, A., Distler, J., Spriewald, B., Spriewald, B., Ramsperger-Gleixner, M., Ensminger, S.M.,... Heim, C. (2018). Blockade of Tyrosine Kinases as Preventive Strategy Against Cardiac Allograft Vasculopathy in a Murine Aortic Transplant Model. (pp. S452-S452).
Biermann, M., Boeltz, S., Pieterse, E., Knopf, J., Rech, J., Bilyy, R.,... Munoz, L.E. (2018). Autoantibodies Recognizing Secondary NEcrotic Cells Promote Neutrophilic Phagocytosis and Identify Patients With Systemic Lupus Erythematosus. Frontiers in Immunology, 9. https://dx.doi.org/10.3389/fimmu.2018.00989
Scholtysek, C., Ipseiz, N., Böhm, C., Krishnacoumar, B., Stenzel, M., Czerwinski, T.,... Krönke, G. (2018). NR4A1 Regulates Motility of Osteoclast Precursors and Serves as Target for the Modulation of Systemic Bone Turnover. Journal of Bone and Mineral Research. https://dx.doi.org/10.1002/jbmr.3533
Gocht, A., Spriewald, B., Distler, J., Ramsperger-Gleixner, M., Ensminger, S.M., Weyand, M., & Heim, C. (2018). Small Molecule Tyrosine Kinase Inhibitor Nintedanib Reduces Development of Cardiac Allograft Vasculopathy in Murine Aortic Allografts. Transplantation Direct, 4(7). https://dx.doi.org/10.1097/TXD.0000000000000804
Zehender, A., Huang, J., Gyoerfi, A.-H., Matei, A.-E., Thuong Trinh-Minh, ., Xu, X.,... Distler, J. (2018). The tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosis. Nature Communications, 9(1). https://dx.doi.org/10.1038/s41467-018-05768-3
Zhang, Y., Pötter, S., Chen, C.-W., Liang, R.f., Gelse, K., Ludolph, I.,... Dees, C. (2018). Poly(ADP-ribose) polymerase-1 regulates fibroblast activation in systemic sclerosis. Annals of the Rheumatic Diseases, 77(5), 744-751. https://dx.doi.org/10.1136/annrheumdis-2017-212265
Rauner, M., Buttgereit, F., Buttgereit, F., Distler, J., Garbe, A.I., Garbe, A.I.,... Zwerina, J. (2018). Osteoimmunology-IMMUNOBONE : Regulation of bone by inflammation. Zeitschrift für Rheumatologie, 77(Suppl 1), 12-15. https://dx.doi.org/10.1007/s00393-018-0455-0
Bergmann, C., Hallenberger, L., Merlevede, B., Brandt, A., Dees, C., Chen, C.-W.,... Distler, J. (2018). XIAP AS NOVEL INTEGRATOR OF TGF BETA SIGNALLING AND CANONICAL WNT SIGNALLING IN TISSUE FIBROSIS. (pp. 739-739).
Zehender, A., Lin, N.-Y., Stefanica, A., Chen, C.-W., Soarel, A., Wohlfahrt, T.,... Distler, J. (2018). TGFB PROMOTES FIBROSIS BY MYST1-DEPENDENT EPIGENETIC REGULATION OF AUTOPHAGY. (pp. 737-737).
Bergmann, C., Merlevede, B., Beyer, C., Hallenberger, L., Brandt, A., Dees, C.,... Distler, J. (2018). THE AP1 TRANSCRIPTION FACTOR CJUN AMPLIFIES HEDGEHOG-INDUCED FIBROBLAST ACTIVATION AND TISSUE FIBROSIS. (pp. 732-733).

Zuletzt aktualisiert 2019-24-04 um 10:31